Your advisor on innovation strategy

Clarify. Decide. Accelerate.

Calsoï helps industrial and technology companies turn an idea into a product that customers actually adopt. The first question we ask in every engagement is simple: "Why will users really adopt this product?" Everything else follows from the answer.

Our difference

A deeply operational approach

"I spent my career doing the work, not commenting on it. That changes the nature of the support I offer. I do not arrive with a packaged method to apply to your situation. I look first at your market, your customers and your real constraints, then I help you decide.

From directly managing teams to resolving a specific challenge, every engagement is concrete and aimed at the growth of your business. I work at the right distance: close enough to grasp your stakes, outside enough to say what an employee would not always voice.

The guiding thread is adoption. A brilliant innovation that nobody uses is worth nothing. A modest innovation the market embraces changes a company. My job is to help you aim for the second."

Jean-Christophe Simon

Services

Four ways to work together

01

Innovation strategy

Innovation strategy means deciding where to put your R&D resources, and where to stop. I build your roadmap with you, then support its implementation: which projects to launch and which to stop, how to allocate budgets, how to organise teams, how to steer the patent portfolio. I ran this exercise for thirty years leading R&D at large groups, in cosmetics, optics and medical devices.

Learn more →

02

Fractional Chief Innovation & R&D Officer

A fractional R&D leader is an experienced director who takes the role a few days a month, without a full-time hire. I take that role with you as an operating partner or in interim leadership, long enough to structure a team, recruit your future director, or get through a critical phase. I have led R&D teams spread across five countries, up to executive committee level.

Learn more →

03

Tech company sell-side advisory

Selling a technology company means making its value legible to the buyer, beyond revenue. I support you from preparation through to identifying acquirers: strategic review, teaser, information memorandum, mapping and approaching buyers, leading discussions. A PhD in physics and a former industrial executive, I translate your technical edge into arguments an acquirer understands and pays for.

Learn more →

04

Focused engagements

A specific issue to handle. Technical or strategic audit of a project, intellectual property review, pre-acquisition due diligence, target identification, Design Thinking workshop. Defined scope, clear deliverable, short timeline.

See example engagements →

Selected engagements

A few recent engagements

Innovation and R&D leadership

  • Creation of an innovation lab (TechLab) for a French company.
  • Long-term engagement directing group R&D at a medical-device group, at executive committee level, with teams in France, Germany, the UK, Romania and the US.
  • R&D Strategy Lead and Advisor at a UK startup applying AI to patents.
  • Operating partner for a deeptech startup in Grenoble, France.

M&A and company sales

  • Sell-side mandate for an electric boat manufacturer.
  • Sell-side mandate for a measuring instruments manufacturer.
  • Pre-due-diligence for a US private equity fund.
  • Setting up an M&A service for technology companies.

Funding and strategy

  • Chair of the board of a B2B startup.
  • Pitch deck improvement for a European leader in smart access (Smart Access) and home automation.

Speaking

  • Talk on user-centered innovation.

Who I work with

A broad spectrum of clients

Large industrial groups

Innovation strategy or intervention on a disruptive project. I have led innovation inside several of them and know their codes.

French mid-cap companies

Accelerating product innovation without building a heavy in-house R&D structure, and through partnerships.

SMEs

Support to general management, focused engagements that call for agility and dialogue.

Deeptech startups and funds

Operating partner, executive reinforcement, Board member or Chairman.

What all these clients have in common: they need an experienced outside perspective.

The advisor

Jean-Christophe Simon

Jean-Christophe Simon

Founder and principal of Calsoï, I bring more than thirty years of leadership in R&D and innovation. Engineer, PhD in physics, I have filed more than thirty patent applications.

My path has been deliberately cross-sector. I worked in cosmetics at L'Oréal then at Kao Corporation. Before serving as Group Innovation Director at Groupe SEB, I led the joint Essilor-Nikon research centre in Japan. At Thuasne, I served as Group R&D Director. I have been advising Maison MGA for five years. I am R&D Strategy Lead and Advisor at a UK startup applying AI to patents. I lived and worked in Japan for six years, an experience that shaped how I lead teams and read a market.

I serve as Foreign Trade Advisor to the French Government (Conseiller du Commerce Extérieur de la France).

Jean-Christophe Simon, innovation and R&D expert  ·  Innovation strategy advisory  ·  Fractional R&D leadership  ·  Technology company divestiture

Selected clients

They trusted us

Advent Advent
Ankar AI Ankar AI
E3i Group E3i Group
Maison MGA Maison MGA
Naviwatt Naviwatt
Nuki Nuki
Thuasne Thuasne
Yole Group Yole Group

La Lettre Calsoï

My readings on the world of innovation

A newsletter where I share what I observe: the disruptions, the stories, the lessons that illuminate the present. Published on Substack in French, and available in English.

All English articles from La Lettre Calsoï →

Full archive, in French →

My Innovation & R&D carousels (30 topics, 2 series) →

Three breakthroughs, one atom, or the Oxford chemist reinventing fluorine
La Lettre Calsoï • 13 July 2026

Three breakthroughs, one atom, or the Oxford chemist reinventing fluorine

While the world debates artificial intelligence, a Belgian chemist based in Oxford is dismantling, one after another, the old certainties of an industry born a hundred and fifty years ago.

On 2 June 2026, a science Grand Prix rewards an Oxford chemist who unsettled a legacy a hundred and forty years old.

Véronique Gouverneur produced fluorine without the hydrofluoric acid no one had managed to remove since Moissan, then learned to recycle the fluorine from the forever pollutants.

Three breakthroughs, ten years apart, and one method: reopening a problem everyone believed closed.

Read the full article
From notebook and pencil to xG, or football's silent revolution
La Lettre Calsoï • 7 July 2026

From notebook and pencil to xG, or football's silent revolution

While everyone celebrated talent and instinct, a handful of contrarians started counting. What they found redrew how matches are won.

In 1950, an accountant notes every pass of a match by hand. No one understands what he is doing.

Sixty years later, expected goals and a Welsh physicist help Liverpool win.

Where everyone decides on feeling, whoever measures gains the edge.

Read the full article
The "literal videos", or the clip that sang what it showed
La Lettre Calsoï • 21 June 2026

The "literal videos", or the clip that sang what it showed

In 2008, a production assistant had an idea so simple no one had dared it: rewrite a music video's lyrics so they describe, word for word, what you see on screen.

In 2008, a production assistant rewrites the lyrics of an old music video so they describe, word for word, what you see on screen.

The format goes viral in days. A hundred imitators follow within a year.

The one who has the idea is not always the one who reaps its fruits.

Read the full article
The Bayeux Tapestry, or seventy metres of innovation
La Lettre Calsoï • 4 June 2026

The Bayeux Tapestry, or seventy metres of innovation

Before printing, before cinema, before the comic strip, a few embroiderers invented a way to tell a story. Nine centuries later, it still stands.

In the late 1070s, a bishop must tell the story of a conquest to an audience that cannot read.

The answer: seventy metres of embroidery, the longest comic strip ever sewn.

Five innovations in one, and a lesson: the most durable breakthroughs are not the most complex.

Read the full article
Rejuvenating a cell, or the biological breakthrough of the century
La Lettre Calsoï • 15 May 2026

Rejuvenating a cell, or the biological breakthrough of the century

While we talk about artificial intelligence, a quieter revolution is redefining what ageing actually is.

Delaying Alzheimer's by three years would have the same effect as curing all cancers today.

Altos Labs and Life Biosciences are revolutionising longevity science, building on the work of Shinya Yamanaka, Juan Carlos Izpisua Belmonte and David A. Sinclair.

Between 2006 and 2026, we have moved from a laboratory curiosity to a regulated clinical reality. Ageing has changed status: from a 'biological destiny', it has become a repairable mechanism.

The challenge of the next five years will be equitable access to these therapies and fine mastery of dosage, to turn reactive medicine into a systemic restoration medicine.

Read the full article
Shackleton, or how to lead when everything falls apart
La Lettre Calsoï • 14 May 2026

Shackleton, or how to lead when everything falls apart

The best manager of the 20th century never led a company. He did something far better.

He lost his ship, his dream, two years of his life. He brought all twenty-eight of his men home.

What Shackleton understood in 1916 is still worth more than any MBA.

Read the full article
When disorder invents the future
La Lettre Calsoï • 1 April 2026

When disorder invents the future

From Fleming to innovation: don't tidy away too quickly what doesn't look like what you expected.

It wasn't a joke and yet he said: "That's funny."

In 1928, Alexander Fleming went on holiday without tidying up his laboratory. On his return, a mould had contaminated his bacterial cultures. Instead of throwing the dish away, he uttered two words: "That's funny."

That bit of negligence gave birth to penicillin and saved hundreds of millions of lives.

The lesson for innovation?

Don't tidy away too quickly what doesn't look like what you expected.

As you well know, chance favours only the prepared mind.

Read the full article

Get each new article delivered straight to your inbox.

Subscribe to La Lettre Calsoï

Frequently asked questions

What clients usually ask

Who is Jean-Christophe Simon?
Jean-Christophe Simon is the founder and principal of Calsoï, an innovation strategy and R&D advisory firm based in the Lyon area, France. A PhD in physics with more than thirty patent applications, he led R&D and innovation for over thirty years, notably as Group Innovation Director at Groupe SEB, Group R&D Director at Thuasne and head of the joint Essilor-Nikon research centre in Japan, after R&D leadership roles at L'Oréal and Kao. He is R&D Strategy Lead and Advisor at Ankar AI, a UK startup applying AI to patents, and a Foreign Trade Advisor to the French Government.
What is Calsoï?
Calsoï is an innovation strategy and R&D advisory firm founded by Jean-Christophe Simon, based in the Lyon area of France. Calsoï helps industrial and technology companies, from large groups to deeptech startups, turn a technological edge into a product the market actually adopts. Engagements range from innovation strategy to fractional R&D leadership and support for the sale of a technology company.
What is a fractional Chief Innovation Officer?
A fractional Chief Innovation Officer is an experienced leader who takes responsibility for a company's R&D or innovation function a few days a month, rather than as a full-time hire. The company gains the experience of a group-level director at a cost suited to its size, while it structures its work or recruits a future permanent leader. At Calsoï, Jean-Christophe Simon takes on this role as an operating partner or in an interim capacity.
When does a deeptech startup need an operating partner?
A deeptech startup needs an operating partner when its technology is solid but the team needs operational reinforcement to scale: structuring R&D, preparing a funding round, convincing an acquirer or a large enterprise customer. Unlike one-off advice, an operating partner works alongside the founders on execution. This is one of the engagements Jean-Christophe Simon takes on through Calsoï.
What is the difference between an innovation consultant and a fractional CIO?
An innovation consultant delivers analysis and recommendations, then leaves. A fractional Chief Innovation Officer takes ownership of execution and leads the teams over time. Calsoï offers both depending on the need, from a one-off diagnostic to hands-on R&D leadership.
How do you sell a technology company?
Selling a technology company runs through several stages: strategic review, preparing a teaser and an information memorandum, identifying and approaching potential acquirers, then supporting discussions through to signing. The value of a technology company rests on assets the buyer must understand, namely patents, know-how and team. Calsoï supports this kind of mandate by making that value legible to the acquirer.
Does Calsoï work with artificial intelligence companies?
Yes. Calsoï works with artificial intelligence companies, from deeptech startups to established players, on innovation strategy, R&D structuring and intellectual property. Jean-Christophe Simon is R&D Strategy Lead and Advisor at a UK startup applying AI to patents. His background as a former industrial innovation director and a deeptech investor lets him bridge AI technical teams and the practical challenge of market adoption.
Which industries does Calsoï serve?
Calsoï works mainly in cosmetics, consumer goods, optics and medical devices, fields where Jean-Christophe Simon led R&D. More broadly, Calsoï supports any industrial or deeptech company whose challenge is to turn a technological edge into a product the market adopts.
Does Calsoï work across Europe and internationally, or only in France?
Calsoï is based in the Lyon area and works across France, but also throughout Europe and internationally in English. Jean-Christophe Simon is R&D Strategy Lead and Advisor at Ankar AI, a UK startup, and the six years he spent in Japan make Calsoï particularly comfortable on projects between Europe and Asia. Both remote and on-site engagements are possible depending on the need.
How do you contact Calsoï?
You can contact Calsoï by email at [email protected] or through Jean-Christophe Simon's LinkedIn profile. Calsoï looks at each request from the company's real need, whether a short focused engagement or longer-term support.

On LinkedIn

Selected publications

La Lettre Calsoï tells the story of innovation through the people who made it, from Fleming to Shackleton. Each issue is a reflection on the craft of the Chief Innovation Officer, technological disruptions, and what the history of science teaches the leaders of today.

The 7 decisions of an R&D Director
Published on LinkedIn

The 7 decisions of an R&D Director

What I wish someone had told me before my first 100 days

I have decided to share what I have learned, in 15 thematic carousels. Each time, a concrete topic: leading an R&D function, driving innovation at the executive committee level, creating an international joint venture, setting up a Corporate Venture fund, transforming an organisation, and so on.

We start today with the 7 decisions an R&D Director must make in their first 100 days.

I have led R&D teams at L'Oréal, Kao, Essilor Group and Nikon, Groupe SEB, Maison MGA and Thuasne. With every new role, the same 7 decisions kept coming back. They are not in the textbooks, but they make all the difference.

If you are an R&D Director or about to become one, this carousel is for you. These are the choices I wish someone had explained to me before I took my first leadership role.

Comment and share if this resonates.

View on LinkedIn
The 5 dimensions of a Chief Innovation Officer
Published on LinkedIn

The 5 dimensions of a Chief Innovation Officer

This role doesn't appear in any textbook. Here is what serving it on the Executive Committee taught me.

The 5 dimensions of a Chief Innovation Officer.

The role of Chief Innovation Officer doesn't appear in any management textbook. When I created this role on the Executive Committee of Groupe SEB, everything had to be invented.

Eight years later, I have come to understand that this role rests on five dimensions. None is sufficient on its own. The five, taken together, change a company's trajectory.

If you hold this role or are considering creating it, here is what experience has taught me.

View on LinkedIn
What if your biggest constraint hides your next innovation lever?
Published on LinkedIn

What if your biggest constraint hides your next innovation lever?

How Air New Zealand turned a regulatory obligation into a viral phenomenon

What if your biggest constraint hides your next innovation lever?

In 2014, Air New Zealand turned a duty no one listens to, the safety video, into a global phenomenon. Directed by Taika Waititi, with Elijah Wood and Peter Jackson, themed around The Hobbit: 16 million views in a week.

What makes this case fascinating, in my view, is the convergence of three dimensions:

→ Turning a forced constraint into a memorable customer experience → Creating value by crossing the worlds of aviation, cinema and tourism → Making regulatory content into a viral brand vehicle

Innovation here is born from a different look at an everyday constraint.

What about you? Which day-to-day obligation in your business deserves to be rethought?

View on LinkedIn
It's not always the discoverer we remember. It's the one who convinces.
Published on LinkedIn

It's not always the discoverer we remember. It's the one who convinces.

What the story of Lemaître and Hubble tells us about leadership in business

It's not always the discoverer we remember. It's the one who convinces.

In 1927, Georges Lemaître, a Belgian priest and physicist, mathematically demonstrated that the universe is expanding.

Two years later, Edwin Hubble published his observations and the famous relation between the velocity and distance of galaxies.

The result: for decades, people would speak of Hubble's law… and Lemaître would remain in the shadows.

It's not always the one with the idea who reaps the benefits, but the one who can formulate it, make it credible and spread it.

In business, the same logic sometimes applies: the one who articulates clearly often leaves a stronger mark than the one who finds.

Isn't true leadership about valuing intuition as much as demonstration?

View on LinkedIn

More than 13,000 readers follow my publications.

Follow me on LinkedIn

Contact

Let's talk about your situation

You have a strategic decision to make, an R&D team to structure, a technology company to divest or a doubt to clear. Tell me about your situation in a few lines, I will reply personally.

Email Calsoï

Connect on LinkedIn